Clinical Research Directory

Inclusion Criteria: * • 40 patients will be recruited in the study. * age ≥ 18 to ≤ 50 years old * achieved three diagnostic items/criteria of ICF will be included in this BET trial: Fatigue lasting over 6 months, which significantly limits daily activities, reducing the person's usual activity level by more than 50%, as confirmed by a doctor. At least three of the following symptoms: Generalized muscle weakness Difficulty sleeping Frequent headaches A painful throat Muscle tenderness throughout the body Migratory joint pain Swollen lymph nodes in the neck or armpits Fatigue lasting more than a day after typical activities Exclusion Criteria: * Patients with a history of medical or complementary treatments for ICF disorder in the 6 months before contracting COVID or after recovery. * Individuals who have engaged in therapeutic exercise, pharmacological treatments, or complementary therapies for post-COVID symptoms within the last six months prior to enrollment. * ICF patients regularly using antidepressants or antipsychotics were excluded. * Those who take sleeping pills regularly were also excluded. * Patients with autoimmune diseases, malignant conditions, anemia, endocrine disorders, systemic diseases, or osteoarthritis affecting the cervical spine, lumbar region, or limbs were excluded. * Individuals with abnormal results in laboratory tests, including neurological, neurophysiological, cardiological, liver/kidney function tests, or urine/stool analyses (as determined by a physician) were excluded.